000 | 01216 a2200361 4500 | ||
---|---|---|---|
005 | 20250514000353.0 | ||
264 | 0 | _c20010823 | |
008 | 200108s 0 0 jpn d | ||
022 | _a0047-1852 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aInazu, A | |
245 | 0 | 0 |
_a[CETP inhibitor]. _h[electronic resource] |
260 |
_bNihon rinsho. Japanese journal of clinical medicine _cMar 2001 |
||
300 |
_a671-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAmides |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArteriosclerosis _xprevention & control |
650 | 0 | 4 |
_aBenzopyrans _xpharmacology |
650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aCholesterol _xanalogs & derivatives |
650 | 0 | 4 | _aCholesterol Ester Transfer Proteins |
650 | 0 | 4 | _aEsters |
650 | 0 | 4 | _aGlycoproteins |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperlipoproteinemias _xdrug therapy |
650 | 0 | 4 |
_aHypolipoproteinemias _xdrug therapy |
650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
650 | 0 | 4 |
_aSulfhydryl Compounds _xpharmacology |
700 | 1 | _aMabuchi, H | |
773 | 0 |
_tNihon rinsho. Japanese journal of clinical medicine _gvol. 59 Suppl 3 _gp. 671-4 |
|
999 |
_c11279815 _d11279815 |